Sera Prognostics (SERA) EBITDA Margin Growth (3y) (2023 - 2026)
Sera Prognostics (SERA) EBITDA Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -178.00 |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -283.00 |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -184.00 |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 72.00 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 1,505.00 |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -3,846.00 |
| 10 | Sera Prognostics | 100.52 Mn | 100.52 Mn | -28,000.00 | -5.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.17 Mn |
| Dec 31, 2025 | -6.42 Mn |
| Sep 30, 2025 | -3.54 Mn |
| Jun 30, 2025 | -3.19 Mn |
| Mar 31, 2025 | 1.19 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Sep 30, 2024 | 1.74 Mn |
| Jun 30, 2024 | -318,583.00 |
| Dec 31, 2023 | 7.17 Mn |
| Sep 30, 2023 | 8.44 Mn |
| Jun 30, 2023 | 6.26 Mn |